Ramipril therapy in integrin α1‐null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA ‐seq analysis
The Journal of Pathology · 2024
DOI: 10.1002/path.6231 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2024. Verfasst von Jacob Madison und 9 weiteren Autor:innen. Beteiligte Einrichtung: Boys Town National Research Hospital, Omaha, NE, USA. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Podocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCRR NIH HHS, NIH HHS.
Abstract (Originalsprache)
The standard of care for patients with Alport syndrome (AS) is angiotensin‐converting enzyme (ACE) inhibitors. In autosomal recessive Alport (ARAS) mice, ACE inhibitors double lifespan. We previously showed that deletion of Itga1 in Alport mice [double‐knockout (DKO) mice] increased lifespan by 50%. This effect seemed dependent on the prevention of laminin 211‐mediated podocyte injury. Here, we treated DKO mice with vehicle or ramipril starting at 4 weeks of age. Proteinuria and glomerular filtration rates were measured at 5‐week intervals. Glomeruli were analyzed for laminin 211 deposition in the glomerular basement membrane (GBM) and GBM ultrastructure was analyzed using transmission electron microscopy (TEM). RNA sequencing (RNA‐seq) was performed on isolated glomeruli at all time points and the results were compared with cultured podocytes overlaid (or not) with recombinant laminin 211. Glomerular filtration rate declined in ramipril‐treated DKO mice between 30 and 35 weeks. Proteinuria followed these same patterns with normalization of foot process architecture in ramipril‐treated DKO mice. RNA‐seq revealed a decline in the expression of Foxc2 , nephrin ( Nphs1 ), and podocin ( Nphs2 ) mRNAs, which was delayed in the ramipril‐treated DKO mice. GBM accumulation of laminin 211 was delayed in ramipril‐treated DKO mice, likely due to a role for α1β1 integrin in CDC42 activation in Alport mesangial cells, which is required for mesangial filopodial invasion of the subendothelial spaces of the glomerular capillary loops. Ramipril synergized with Itga1 knockout, tripling lifespan compared with untreated ARAS mice. © 2023 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Boys Town National Research Hospital, Omaha, NE, USA.
ORCID-Profile: Dominic Cosgrove
Förderung
- NIGMS NIH HHS
- NCRR NIH HHS
- NIH HHS
- NIDCD NIH HHS
- National Institute of General Medical Sciences
- National Institutes of Health
- National Center for Research Resources
Zitieren
APA
Madison, J., Wilhelm, K., Meehan, D. T., Gratton, M. A., Vosik, D., Samuelson, G., Ott, M., Fascianella, J., Nelson, N., & Cosgrove, D. (2024). Ramipril therapy in integrin α1‐null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA ‐seq analysis. The Journal of Pathology. https://doi.org/10.1002/path.6231
Vancouver
Madison J, Wilhelm K, Meehan DT, Gratton MA, Vosik D, Samuelson G, et al. Ramipril therapy in integrin α1‐null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA ‐seq analysis. The Journal of Pathology. 2024. doi:10.1002/path.6231
BibTeX
@article{Madison2024,
author = {Madison, Jacob and Wilhelm, Kevin and Meehan, Daniel T and Gratton, Michael Anne and Vosik, Denise and Samuelson, Gina and Ott, Megan and Fascianella, John and Nelson, Noa and Cosgrove, Dominic},
title = {Ramipril therapy in integrin α1‐null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA ‐seq analysis},
journal = {The Journal of Pathology},
year = {2024},
doi = {10.1002/path.6231}
}
EUVIMED